Citigroup’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.17M | Sell |
126,892
-78,756
| -38% | -$3.83M | ﹤0.01% | 1277 |
|
|
2025
Q1 | $7M | Buy |
205,648
+95,292
| +86% | +$3.24M | ﹤0.01% | 1175 |
|
|
2024
Q4 | $4.34M | Buy |
110,356
+85,934
| +352% | +$3.38M | ﹤0.01% | 1533 |
|
|
2024
Q3 | $1.15M | Sell |
24,422
-13,682
| -36% | -$643K | ﹤0.01% | 2464 |
|
|
2024
Q2 | $2.06M | Sell |
38,104
-63,365
| -62% | -$3.42M | ﹤0.01% | 1747 |
|
|
2024
Q1 | $6.92M | Sell |
101,469
-9,616
| -9% | -$655K | ﹤0.01% | 1081 |
|
|
2023
Q4 | $6.95M | Sell |
111,085
-1,026
| -0.9% | -$64.2K | ﹤0.01% | 976 |
|
|
2023
Q3 | $5.09M | Buy |
112,111
+3,617
| +3% | +$164K | ﹤0.01% | 1026 |
|
|
2023
Q2 | $6.09M | Sell |
108,494
-82,521
| -43% | -$4.63M | ﹤0.01% | 1005 |
|
|
2023
Q1 | $8.64M | Buy |
191,015
+66,067
| +53% | +$2.99M | 0.01% | 899 |
|
|
2022
Q4 | $5.08M | Buy |
124,948
+8,354
| +7% | +$340K | ﹤0.01% | 1058 |
|
|
2022
Q3 | $7.62M | Buy |
116,594
+25,340
| +28% | +$1.66M | 0.01% | 910 |
|
|
2022
Q2 | $5.55M | Buy |
91,254
+60,876
| +200% | +$3.7M | ﹤0.01% | 1078 |
|
|
2022
Q1 | $1.91M | Sell |
30,378
-410
| -1% | -$25.8K | ﹤0.01% | 1809 |
|
|
2021
Q4 | $2.33M | Buy |
30,788
+2,275
| +8% | +$172K | ﹤0.01% | 1853 |
|
|
2021
Q3 | $3.19M | Sell |
28,513
-4,648
| -14% | -$520K | ﹤0.01% | 1558 |
|
|
2021
Q2 | $5.37M | Buy |
33,161
+7,135
| +27% | +$1.15M | ﹤0.01% | 1373 |
|
|
2021
Q1 | $3.17M | Buy |
26,026
+4,765
| +22% | +$581K | ﹤0.01% | 1643 |
|
|
2020
Q4 | $3.26M | Sell |
21,261
-14,151
| -40% | -$2.17M | ﹤0.01% | 1443 |
|
|
2020
Q3 | $2.96M | Sell |
35,412
-9,802
| -22% | -$820K | ﹤0.01% | 1329 |
|
|
2020
Q2 | $3.32M | Sell |
45,214
-14,489
| -24% | -$1.06M | ﹤0.01% | 1293 |
|
|
2020
Q1 | $2.53M | Buy |
59,703
+34,625
| +138% | +$1.47M | ﹤0.01% | 1258 |
|
|
2019
Q4 | $1.53M | Buy |
25,078
+15,935
| +174% | +$970K | ﹤0.01% | 1882 |
|
|
2019
Q3 | $375K | Sell |
9,143
-5,347
| -37% | -$219K | ﹤0.01% | 2730 |
|
|
2019
Q2 | $683K | Sell |
14,490
-2,466
| -15% | -$116K | ﹤0.01% | 2456 |
|
|
2019
Q1 | $605K | Sell |
16,956
-42
| -0.2% | -$1.5K | ﹤0.01% | 2352 |
|
|
2018
Q4 | $486K | Buy |
16,998
+5,603
| +49% | +$160K | ﹤0.01% | 2519 |
|
|
2018
Q3 | $505K | Buy |
11,395
+1,278
| +13% | +$56.6K | ﹤0.01% | 2521 |
|
|
2018
Q2 | $595K | Buy |
10,117
+8,795
| +665% | +$517K | ﹤0.01% | 2221 |
|
|
2018
Q1 | $61K | Buy |
1,322
+17
| +1% | +$784 | ﹤0.01% | 3640 |
|
|
2017
Q4 | $30K | Buy |
1,305
+1,295
| +12,950% | +$29.8K | ﹤0.01% | 4053 |
|
|
2017
Q3 | $0 | Buy |
+10
| New | – | ﹤0.01% | 4718 |
|
|
2017
Q2 | – | Sell |
-100
| Closed | -$2K | – | 4878 |
|
|
2017
Q1 | $2K | Buy |
+100
| New | +$2K | ﹤0.01% | 4632 |
|